Hayley Simpson, Senior Director of Commercial Strategy“We have built a reputation for excellence by bringing together an extensive community of professionals through our flagship Biomarkers Series and Omics Series,” says Hayley Simpson, Senior Director of Commercial Strategy. “These events have been instrumental in fostering innovation and collaboration, providing the life sciences community with cutting-edge content through webinars, science exchanges, and e-books.”
To achieve this, the company ensures that collaboration is the cornerstone of its approach. Oxford Global Marketing works closely with an advisory board of thought leaders within life sciences to ensure that the events showcase the most exciting advancements and address current challenges in the industry. This collaborative effort is crucial in overcoming barriers and facilitating breakthroughs within the vibrant ecosystem of precision medicine.
Exemplary Event Management Services
Oxford Global Marketing’s events are designed with the audience in mind. From selecting the right topics and speakers to ensuring relevant solution providers are present, every aspect of the company’s events is tailored to drive fruitful discussions and support peer-to-peer collaboration. Its innovative program and networking formats are crafted to maximize the value of face-to-face interactions and education.
The company’s exemplary event management services include taking feedback from attendees and highlighting the high-level programs, focused networking sessions, and personalized touches, such as one-to-one meetings, as key contributors to a successful and beneficial experience. The company prides itself on the exemplary management of its events, which is reflected in the satisfaction and repeated participation of its partners.
Takara Bio has been a repeat sponsor of NextGen Omics UK at the Gold and Platinum tiers for seven consecutive years. They attribute their continued participation to Oxford Global Marketing’s seamless integration of exhibitions, fitting delegate attendance, and unmatched event management. The company’s commitment to conducting thorough research and consultation with its partners ensures that events are tailored to meet specific metrics and connect the right people.
Takara Bio, an international provider of reagents and scientific instruments, serves as a prime example of Oxford Global’s successful partnerships. For over 50 years, Takara has been delivering high-quality products and services to the life sciences community. Their focus on next-generation sequencing solutions aligns perfectly with Oxford Global Marketing’s NextGen Omics series. The event’s location in London, a key area for Takara’s lead acquisition, further enhances its relevance.
“We have built a reputation for excellence by bringing together an extensive community of professionals through our flagship Biomarkers Series and Omics Series.”
A Proven Track Record of Success
As Oxford Global Marketing looks to 2025, its forwardthinking approach and commitment to customer-centric events are set to create a significant impact in the life sciences industry.
The company is set to elevate its impact even further by merging its two leading series into the highly anticipated ‘Precision Medicine’ brand. This new initiative will encompass four must-attend events across the US and Europe: Biomarkers & Precision Medicine UK & US and NextGen Omics & Spatial Multi-Omics UK & US. This strategic move aims to create a more cohesive and comprehensive platform for professionals to explore the latest advancements in precision medicine.
With a proven track record of success and a vision for the future, Oxford Global is poised to continue leading the way in driving impactful results within the life sciences community.
“We fuel accelerated breakthroughs in precision medicine by providing scientists with the interdisciplinary knowledge and key technologies they require to turn human data into precise, patient-centric solutions,” says Simpson.
Advancing Precision Medicine Through Innovation: The Oxford Global Vision
Mike Burden, Director of Production & Content – Precision Medicine Brand
Oxford Global's Precision Medicine Brand drives progress by uniting diverse stakeholders, sharing expert insights and groundbreaking technologies, and serving as a platform for collaboration that transforms research into actionable healthcare advancements that improve patient outcomes.
